Vietnam.vn - Nền tảng quảng bá Việt Nam

VNVC Vaccine Company and Sanofi Pharmaceutical Group cooperate in transferring vaccine production technology

(Chinhphu.vn) - On May 26, in the presence of President Luong Cuong and President of the French Republic Emmanuel Macron, Vietnam Vaccine Company (VNVC) and Sanofi Pharmaceutical Group (France) exchanged a cooperation agreement document on transferring Sanofi's vaccine production technology at the Vaccine and Biological Products Factory, Vietnam.

Báo Chính PhủBáo Chính Phủ26/05/2025

Công ty Vaccine VNVC và Tập đoàn dược phẩm Sanofi hợp tác chuyển giao công nghệ sản xuất vaccine - Ảnh 1.

Mr. Ngo Chi Dung and Ms. Zainab Sadat Qayyum, President of Sanofi Southeast Asia - India, exchanged documents on cooperation agreement on vaccine production technology transfer in the presence ofthe President.

The event took place within the framework of the French President's State visit to Vietnam, at the invitation of President Luong Cuong. The visit is of special significance as the two countries have just upgraded their relationship to a comprehensive strategic partnership since October 2024, during the official visit to France by General Secretary To Lam .

Speaking at a press conference after the document handover ceremony, President Luong Cuong said that Vietnam and France have agreed to promote cooperation in new areas of strength and potential such as aerospace, nuclear energy, artificial intelligence (AI), digital transformation, pharmaceuticals and promote technology transfer on the basis of recognizing the positive results of traditional cooperation areas.

Accordingly, the agreement on vaccine production technology transfer between VNVC Vaccine Company and the leading French pharmaceutical group - Sanofi is a concrete demonstration in realizing the strategic cooperation between the two countries, laying the foundation for the development of bilateral relations in the health sector, not only in trade and human resource training, but also in expanding and enhancing the field of scientific research cooperation, technology transfer, and high-tech vaccine production.

The cooperation is expected to bring great and long-term benefits to the people of the two countries in the fields of medicine and health care, while creating momentum and a solid legal basis for bilateral activities in medicine, pharmaceuticals, and vaccines in the coming time.

This is also an important step for the Vietnamese health sector to expand international cooperation in advanced science and technology, proactively step by step to strengthen national health security, improve the capacity to respond to future epidemic challenges, create a solid foundation for outstanding development in the biomedical field, and bring practical benefits to the people.

Công ty Vaccine VNVC và Tập đoàn dược phẩm Sanofi hợp tác chuyển giao công nghệ sản xuất vaccine - Ảnh 2.

When many of these vaccines are produced in Vietnam, the supply will be abundant, the price will decrease, bringing the opportunity for full vaccination, protecting the health of many children and adults - Photo: VGP/Moc Mien

Access to the world's leading modern technologies

According to the cooperation agreement, VNVC and Sanofi will gradually transfer technology to produce some important Sanofi vaccines used in large quantities in Vietnam such as 6-in-1 vaccine for children, flu vaccine, meningococcal meningitis vaccine for children and adults.

Sanofi also accompanies VNVC in training human resources and quality management in vaccine research and production.

Sharing about the significance of this cooperation, Mr. Ngo Chi Dung, General Director and Chairman of the Board of Directors of VNVC Vaccine Company, said that in the context that the Party and the State are creating the most favorable conditions for the development of the private economy, especially in the field of international cooperation in science and technology, the cooperation in technology transfer with Sanofi, France - the world's leading vaccine manufacturer is an important cooperation, helping VNVC in particular, and the Vietnamese vaccine manufacturing industry in general, to quickly improve the production capacity of high-quality Made in Vietnam vaccines on par with the world.

Technology transfer will allow Vietnam to quickly access leading modern technologies, optimize research and development activities, promptly serve domestic needs and firmly ensure national health security.

"The cooperation agreement with Sanofi, a pharmaceutical group with more than 100 years of experience and global influence, is an opportunity for Vietnam to access the world's leading vaccine production technology, thereby being able to proactively produce hundreds of millions of doses of high-quality vaccines each year to serve domestic needs and even export.

"Proactive domestic production will help ensure adequate supply of high-quality vaccines and reduce vaccine costs for people, which is of great significance in the vaccine coverage strategy, protecting the health of all people, thereby reducing the burden of disease, reducing medical examination and treatment costs, and improving the quality of life," Mr. Ngo Chi Dung expected.

In its strategic vision of contributing to the goal of national vaccine self-sufficiency, VNVC plans to build a modern VNVC Vaccine and Biological Products Factory, with a scale of up to 26,000 m2 in Long An province. With an initial investment of VND 2,000 billion, the VNVC vaccine factory is designed to meet the highest standards of the most modern Good Manufacturing Practices (GMP) of the World Health Organization (WHO), the European Union (EU), and the US Food and Drug Administration (FDA).

Sanofi is providing tens of millions of doses of high-quality vaccines to serve the needs of vaccination services in Vietnam such as 6-in-1 Hexaxim, 4-in-1 Tetraxim, 3-in-1 diphtheria-pertussis-tetanus Adacel, Japanese encephalitis Imojev, rabies Verorab, meningococcal meningitis Menactra, hepatitis A Avaxim, quadrivalent influenza Vaxigrip Tetra, typhoid Typhim VI.

Most of these vaccines are safely supplied and administered at the VNVC vaccination system of more than 220 centers nationwide. It is expected that when these vaccines are produced in Vietnam, there will be an abundant supply and reduced costs, providing the opportunity for full vaccination and health protection for many children and adults.

Hien Minh


Source: https://baochinhphu.vn/cong-ty-vaccine-vnvc-va-tap-doan-duoc-pham-sanofi-hop-tac-chuyen-giao-cong-nghe-san-xuat-vaccine-102250526151910298.htm


Comment (0)

No data
No data

Heritage

Figure

Business

No videos available

News

Political System

Local

Product